The deal priced below last closing price of $28.03. Goldman Sachs, Jefferies, TD Cowen and Stifel are acting as joint book running managers for the offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RAPP:
- Closing Bell Movers: Nebius up over 40% on Microsoft deal
- Rapport Therapeutics Terminates Common Stock Prospectus
- Rapport Therapeutics announces $250M common stock offering
- Rapport Therapeutics price target raised to $56 from $35 at Stifel
- EchoStar sells spectrum licenses to SpaceX, StubHub to launch IPO: Morning Buzz